HUGO BIOTECH is a developer of cloud-based pathogenic microorganism data analysis system PACE. The device is used for image capture, visualization, and biological significance analysis. The Illumina Genetic Analyzer Pipeline software is used to perform preliminary analysis on the data to obtain conversion from image capture to intensity signal value, and then calculate to base sequence. It helps to determine the DNA sequence of pathogenic microorganisms in clinical samples like cerebrospinal flu Founded in 2017, headquartered in Beijing, China. The company has raised $33.5M at the Series A stage backed by investors including Chuangxin Innovation Works, CD Capital, NLVC, Sinovation Ventures, Shanghai Healthcare Capital. Operating in HealthTech > Life Sciences Tech, Life Sciences > Life Sciences Tech.
Hugo Biotech
Series AHUGO BIOTECH is a developer of cloud-based pathogenic microorganism data analysis system PACE. The device is used for image capture, visualization, and biological significance analysis. The Illumina Genetic Analyzer Pipeline software is used to perform preliminary analysis on the data to obtain conversion from image capture to intensity signal value, and then calculate to base sequence. It helps to determine the DNA…
About
Business model
Life Sciences Tech > Research & Development > Drug Informatics > Clinical Data Analysis > Omics Analysis,
Genomics > Enabling Technologies > Instrument Systems > Nucleic Acid Analysis > Sequencing
Founders & team highlights
Serial Founder
Institutional investors
Latest coverage
📰 Browse funding news — rounds, valuations, and market moves for founders.
Investor directory
🗂️ See who's investing in HealthTech — full fund directory with check size and geography.